| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.25 | 9e-14 |
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | 0.24 | 6e-11 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | 0.19 | 7e-09 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.21 | 8e-09 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.19 | 1e-07 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.25 | 3e-07 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.16 | 4e-06 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | 0.14 | 1e-05 |
| mRNA | Sunitinib | FIMM | pan-cancer | AAC | 0.77 | 1e-05 |
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | 0.73 | 1e-05 |